You are here

Roche

Roche gets some regulatory love for its breakthrough quest on a PhIII Huntington’s drug

Endpoints

Fri, 08/3/18 - 11:31 pm

Huntington's disease

Pfizer Receives European Approval for Herceptin Biosimilar, Trazimera

CP Wire

Tue, 07/31/18 - 12:30 pm

On top of expiring Herceptin patents, Roche faces huge royalty losses in 2019

Endpoints

Thu, 07/26/18 - 11:22 am

Cabilly patents

Can Celgene's latest Revlimid win reverse the company's bad-news streak?

Fierce Pharma

Tue, 07/24/18 - 06:00 pm

clinical trials

non-Hodgkin lymphoma

PureTech Receives Up To $36 Million from Roche to Develop Oral Delivery of Antisense Oligonucleotides

CP Wire

Fri, 07/20/18 - 11:29 am

drug development

Roche has taken the Trump pledge, joining Pfizer, Novartis and Merck in promising to hold the line on drug prices

Endpoints

Fri, 07/20/18 - 09:47 am

Is Roche's latest Tecentriq win really a win for Merck's Keytruda?

Fierce Pharma

Thu, 07/19/18 - 11:14 am

immuno-oncology

non-small cell lung cancer

Roche’s antiviral hits flu targets in PhIII trial

Pharma Times

Tue, 07/17/18 - 10:06 am

baloxavir marboxil

Many Drugmakers Ignore Trump—and Raise Prices Anyway

Bloomberg

Sun, 07/15/18 - 12:52 pm

Pharmas call off price hikes after California law forces new warnings: report

Fierce Pharma

Wed, 07/11/18 - 11:15 pm

Gilead Sciences

3 Best Biotech Acquisitions of 2018 (So Far)

Motley Fool

Thu, 07/5/18 - 09:57 am

Juno Therapeutics

Foundation Medicine

FDA Limits the Use of Tecentriq and Keytruda

RAPS.org

Wed, 07/4/18 - 11:25 am

metastatic urothelial cancer

Roche vaults into lead in frontline triple negative breast cancer as Tecentriq/Abraxane combo aces progression-free survival

Endpoints

Mon, 07/2/18 - 09:37 am

triple negative breast cancer

The first single-dose flu drug nod could be FDA’s Christmas present for Roche

Fierce Pharma

Tue, 06/26/18 - 10:10 pm

With latest data, has Roche's Tecentriq found a blockbuster lung cancer niche?

Fierce Pharma

Mon, 06/25/18 - 12:39 pm

clinical trials

small cell lung cancer

Tesaro stock rockets as rumours of Roche takeover abound

Pharmaforum

Fri, 06/22/18 - 10:21 pm

FDA limits first-line bladder cancer labels for Keytruda, Tecentriq

Biopharma Dive

Fri, 06/22/18 - 12:13 pm

Finding Cancer Patients Is the Pharma Industry’s Unlikely Challenge

Bloomberg

Wed, 06/20/18 - 11:44 am

In a Genentech Redux, Roche Pays $2.4B for Rest of Foundation Medicine

Xconomy

Tue, 06/19/18 - 10:50 am

Foundation Medicine

Roche CEO Severin Schwan isn’t about to tamper with a winning R&D strategy now, but he’s still looking for ways to cut costs

Endpoints

Tue, 06/12/18 - 10:31 pm

Pages